Recombinant Anti-human EFNB2 Antibody scFv Fragment (CAT#: MOB-304-S(P))

1. Q 1: How does the anti-human EFNB2 scFv antibody enable precise localization in single-cell immunofluorescence analysis?

   A: In single-cell immunofluorescence analysis, the anti-human EFNB2 scFv antibody binds specifically to the EFNB2 protein within individual cells. Its small scFv fragment allows for better tissue penetration and minimal steric hindrance, resulting in highly precise localization of EFNB2. This precision enables quantitative analysis of EFNB2 expression levels and distribution patterns at the single-cell level, providing detailed insights into cellular functions and signaling mechanisms.

2. Q 2: How does EFNB2 contribute to neurodegenerative diseases, and how can this antibody aid in research?

   A: EFNB2 is involved in neurodevelopment and synaptic plasticity. Abnormal expression or post-translational modifications of EFNB2 have been associated with neurodegenerative diseases like Alzheimer's and Parkinson's. The anti-human EFNB2 scFv antibody enables researchers to detect and quantify these alterations in EFNB2, helping to elucidate its role in disease onset and progression. This aids in understanding the molecular mechanisms underlying neurodegeneration and could inform therapeutic strategies.

3. Q 3: What sensitivity advantages does this antibody have in detecting EFNB2 compared to similar products?

   A: The anti-human EFNB2 scFv antibody exhibits high sensitivity due to its strong affinity for EFNB2 and low non-specific binding. It can detect even low levels of EFNB2, making it superior for applications requiring precise quantification. This sensitivity is particularly beneficial in early disease detection, when EFNB2 expression changes may be subtle but significant.

View the frequently asked questions answered by Creative Biolabs Support.